What is axonics?

Axonics Modulation Technologies is a medical technology company that specializes in the development and commercialization of innovative implantable neuromodulation devices for the treatment of urinary and fecal dysfunction. Their flagship product is the Axonics Sacral Neuromodulation System, which is designed to treat overactive bladder, fecal incontinence, and urinary retention.

The Axonics system consists of a small implantable rechargeable device that delivers mild electrical stimulation to the nerves in the sacral region, helping to modulate the communication between the brain and the bladder or bowel. The system is controlled by a programming device that allows healthcare professionals to adjust the stimulation parameters to meet the individual needs of each patient.

Axonics received FDA approval for their Sacral Neuromodulation System in December 2019 and has since been approved for use in Europe, Canada, and Australia. The company is headquartered in Irvine, California, and is dedicated to improving the quality of life for patients suffering from urinary and fecal dysfunction through the development of cutting-edge neuromodulation technology.